Clinical trial
Clinical Pharmacogenomics of Antidepressant Response
NCT00384020 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00384020 |
|---|---|
| Title | Clinical Pharmacogenomics of Antidepressant Response |
| Official title | Phase 4 Clinical Pharmacogenomics of Antidepressant Response |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Science and Technology Council, Taiwan Chang Gung Memorial Hospital Taipei Medical University WanFang Hospital Taipei City Hospital Mackay Memorial Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Paroxetine (Seroxat), Escitalopram (Lexapro) |
| Enrollment | 402 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Oct 4, 2006 |
| Last update posted | Feb 1, 2010 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: